References
- Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48. doi:https://doi.org/10.2147/cmar.S149619
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42. doi:https://doi.org/10.1016/j.cgh.2019.07.045
- Li G, Yu S, Xu J, Zhang X, Ye J, Wang Z, He Y. The prognostic role of Helicobacter pylori in gastric cancer patients: a meta-analysis. Clin Res Hepatol Gastroenterol. 2019;43(2):216–24. doi:https://doi.org/10.1016/j.clinre.2018.08.012
- Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24(26):2818–32. doi:https://doi.org/10.3748/wjg.v24.i26.2818
- Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67. doi:https://doi.org/10.1007/s11912-019-0820-4
- El-Guindy DM, Wasfy RE, Abdel Ghafar MT, Ali DA, Elkady AM. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival. J Egypt Natl Canc Inst. 2019;31(1):3. doi:https://doi.org/10.1186/s43046-019-0005-0
- Abdel Ghafar MT, Gharib F, Abdel-Salam S, Elkhouly RA, Elshora A, Shalaby KH, El-Guindy D, El-Rashidy MA, Soliman NA, Abu-Elenin MM, et al. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer. Mol Biol Rep. 2020;47(4):2509–19. doi:https://doi.org/10.1007/s11033-020-05334-5
- Ghafar MTA, Gharib F, Al-Ashmawy GM, Mariah RA. Serum high-temperature-required protein A2: a potential biomarker for the diagnosis of breast cancer. Gene Rep. 2020;20:100706. doi:https://doi.org/10.1016/j.genrep.2020.100706
- Kwak Y, Seo AN, Lee HE, Lee HS. Tumor immune response and immunotherapy in gastric cancer. J Pathol Transl Med. 2020;54(1):20–33. doi:https://doi.org/10.4132/jptm.2019.10.08
- Cui X, Jia Z, Chen D, Xu C, Yang P. The prognostic value of the C-reactive protein to albumin ratio in cancer: an updated meta-analysis. Medicine (Baltimore). 2020;99(14):e19165. doi:https://doi.org/10.1097/md.0000000000019165
- Fang E, Wang X, Feng J, Zhao X. The prognostic role of Glasgow prognostic score and C-reactive protein to albumin ratio for sarcoma: a system review and meta-analysis. Dis Markers. 2020;2020:8736509. doi:https://doi.org/10.1155/2020/8736509
- Zhou W, Zhang GL. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: a meta-analysis. PLoS One. 2019;14(10):e0224266. doi:https://doi.org/10.1371/journal.pone.0224266
- Deng TB, Zhang J, Zhou YZ, Li WM. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer. Medicine (Baltimore). 2018;97:e13505. doi:https://doi.org/10.1097/md.0000000000013505
- Liu HC, Chen YJ, Xu YF, Xu ZH, Xu YC. Effect of preoperative ratio of C reactive protein to albumin on prognosis of patients with gastric cancer. Chin J Lab Diagn. 2018;22:27–9.
- Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, Xu D. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–45. doi:https://doi.org/10.1016/j.tranon.2015.06.006
- Liu X, Wu Z, Lin E, Li W, Chen Y, Sun X, Zhou Z. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy. Clin Nutr. 2019;38(4):1853–60. doi:https://doi.org/10.1016/j.clnu.2018.07.015
- Lu J, Xu B-B, Zheng Z-F, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, Cao L-L, Lin M, Tu R-H, et al. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial. Gastric Cancer. 2019;22(3):536–45. doi:https://doi.org/10.1007/s10120-018-0892-0
- Mao M, Wei X, Sheng H, Chi P, Liu Y, Huang X, Xiang Y, Zhu Q, Xing S, Liu W, et al. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol Lett. 2017;14:7417–24. doi:https://doi.org/10.3892/ol.2017.7179
- Ni XF, Wu J, Ji M, Shao YJ, Zhou WJ, et al. Prognostic value of C-reactive protein/albumin ratio in patients receiving first-line palliative chemotherapy with unresectable stage IV gastric cancer. Int J Clin Exp Path. 2016;9:12785–96.
- Toiyama Y, Shimura T, Yasuda H, Fujikawa H, Okita Y, Kobayashi M, Ohi M, Yoshiyama S, Hiro J, Araki T, et al. Clinical burden of C-reactive protein/albumin ratio before curative surgery for patients with gastric cancer. Anticancer Res. 2016;36(12):6491–8. doi:https://doi.org/10.21873/anticanres.11248
- Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:https://doi.org/10.1371/journal.pmed.1000097
- Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2009. http://wwwohrica/programs/clinical_epidemiology/oxfordasp.
- Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y, et al. Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–25. doi:https://doi.org/10.1007/s00268-017-4400-1
- Toyokawa T, Muguruma K, Tamura T, Sakurai K, Amano R, Kubo N, Tanaka H, Yashiro M, Hirakawa K, Ohira M, et al. Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer. Oncotarget. 2018;9(50):29351–64. doi:https://doi.org/10.18632/oncotarget.25486
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7. doi:https://doi.org/10.1038/nature01322
- Zhang D, Yan H, Wei Y, Liu X, Zhuang Z, Dai W, Li J, Li W, Hang C. C-reactive protein/albumin ratio correlates with disease severity and predicts outcome in patients with aneurysmal subarachnoid hemorrhage. Front Neurol. 2019;10:1186. doi:https://doi.org/10.3389/fneur.2019.01186
- Agsalda-Garcia M, Shieh T, Souza R, Kamada N, Loi N, Oda R, Acosta-Maeda T, Choi SY, Lim E, Misra A, et al. Raman-Enhanced Spectroscopy (RESpect) probe for childhood non-hodgkin lymphoma. Scimed J. 2020;2(1):1–7. doi:https://doi.org/10.28991/SciMedJ-2020-0201-1
- Yavari K. Anti-angiogenesis therapy of cancer cells using 153Sm-Bevasesomab. ESJ. 2018;2(3):130–9. doi:https://doi.org/10.28991/esj-2018-01136
- Zare H. Effects of Salvia officinalis extract on the breast cancer cell line. SciMedicine J. 2019;1:25–9. doi:https://doi.org/10.28991/SciMedJ-2019-0101-4